Mint Medical is on the front lines in the fight against COVID-19, proving that radiology can act as a role model for gathering evidence by utilizing structured data.
In this webcast, Prof. Dr. Maria-Katharina Ganten and Gabriel Salg highlight the urgent need for structured data collection, as well as the importance of data quality, integrity, and traceability. The hosts discuss how to support trial compatible data acquisition in routine work by example of a European multicenter project.
Prof. Ganten and Mr. Salg also provide a look to the future in which radiology has the opportunity to set standards for new research strategies, not only concerning COVID studies but rather for any disease or treatment.
-
37 minute(s)
Clinical trial excellence for routine covid-19 assessment
Related Resources
Related Resources
University Hospital Munich (LMU): Study Analyzing the Tumor Growth Rate as a Prognostic Biomarker in Lymphoma Patients Under CAR T-Cell Therapy
A recent study[1] conducted by researchers at the University Hospital Munich (LMU) investigated the role of tumor growth rate (TGR) in predicting the…
Advancing Neuro-Oncology Assessments: Mint Medical to Integrate Newly Published RANO 2.0 Criteria into mint Lesion™
Glioblastomas and other gliomas are the most common malignant primary brain tumor types, yet few effective therapies are available. Clinical research…
Study Highlights the Potential of Radiomics in Medical Intervention
A recent study conducted by the Medical University of Innsbruck highlights the potential of radiomics in exploring the impacts of Radiochemotherapy…